keyword
https://read.qxmd.com/read/38628284/giant-hepatic-hemangioma-in-a-patient-with-cirrhosis-challenging-to-manage
#1
JOURNAL ARTICLE
Marlone Cunha-Silva, Clauber Teles Veiga, Larissa Bastos Eloy da Costa, Simone Reges Perales, Amanda Avesani Cavotto Furlan, Elaine Cristina de Ataíde, Ilka de Fátima Santana Ferreira Boin, Tiago Sevá-Pereira
Giant hepatic hemangiomas are occasional in patients with cirrhosis. It remains a challenge to decide on the need for treatment and choose the most appropriate intervention. A 62-year-old woman was recently diagnosed with cirrhosis and complained of upper abdominal fullness, reduction in oral food intake, and weight loss of 6 kg over the last three years. Upper digestive endoscopy evidenced thin-caliber esophageal varices and significant extrinsic compression of the lesser gastric curvature. Abdominal computed tomography revealed an exophytic tumor in the left hepatic lobe, measuring 11...
2024: Autopsy & Case Reports
https://read.qxmd.com/read/38619429/marc1-in-masld-modulation-of-lipid-accumulation-in-human-hepatocytes-and-adipocytes
#2
JOURNAL ARTICLE
Amanda K Jones, Besnik Bajrami, Morgan K Campbell, Abdullah Mesut Erzurumluoglu, Qiusha Guo, Hongxing Chen, Xiaomei Zhang, Svetlana Zeveleva, David Kvaskoff, Andreas-David Brunner, Stefanie Muller, Vasudha Gathey, Rajvee M Dave, James W Tanner, Sophia Rixen, Michel A Struwe, Kathryn Phoenix, Kaitlyn J Klumph, Heather Robinson, Daniel Veyel, Annkatrin Muller, Boris Noyvert, Boris Alexander Bartholdy, Agnes A Steixner-Kumar, Jan Stutzki, Dmitriy Drichel, Steffen Omland, Ryan Sheehan, Jon Hill, Tom Bretschneider, Dirk Gottschling, Axel J Scheidig, Bernd Clement, Martin Giera, Zhihao Ding, John Broadwater, Curtis R Warren
BACKGROUND: Mutations in the gene MTARC1 (mitochondrial amidoxime-reducing component 1) protect carriers from metabolic dysfunction-associated steatohepatitis (MASH) and cirrhosis. MTARC1 encodes the mARC1 enzyme, which is localized to the mitochondria and has no known MASH-relevant molecular function. Our studies aimed to expand on the published human genetic mARC1 data and to observe the molecular effects of mARC1 modulation in preclinical MASH models. METHODS AND RESULTS: We identified a novel human structural variant deletion in MTARC1, which is associated with various biomarkers of liver health, including alanine aminotransferase levels...
May 1, 2024: Hepatology Communications
https://read.qxmd.com/read/38616215/organizational-and-implementation-factors-associated-with-cirrhosis-care-in-the-veterans-health-administration
#3
JOURNAL ARTICLE
Heather McCurdy, Anna Nobbe, Dawn Scott, Heather Patton, Timothy R Morgan, Jasmohan S Bajaj, Vera Yakovchenko, Monica Merante, Sandra Gibson, Carolyn Lamorte, Gyorgy Baffy, George N Ioannou, Tamar H Taddei, Karine Rozenberg-Ben-Dror, Jennifer Anwar, Jason A Dominitz, Shari S Rogal
BACKGROUND: The Veterans Health Administration provides care to more than 100,000 Veterans with cirrhosis. AIMS: This implementation evaluation aimed to understand organizational resources and barriers associated with cirrhosis care. METHODS: Clinicians across 145 Department of Veterans Affairs (VA) medical centers (VAMCs) were surveyed in 2022 about implementing guideline-concordant cirrhosis care. VA Corporate Data Warehouse data were used to assess VAMC performance on two national cirrhosis quality measures: HCC surveillance and esophageal variceal surveillance or treatment (EVST)...
April 14, 2024: Digestive Diseases and Sciences
https://read.qxmd.com/read/38611656/improved-applicability-and-diagnostic-accuracy-of-the-novel-spleen-dedicated-transient-elastography-device-for-high-risk-esophageal-varices
#4
JOURNAL ARTICLE
Anita Madir, Mislav Barisic Jaman, Marko Milosevic, Petra Dinjar Kujundžić, Ivica Grgurevic
Spleen stiffness measurement (SSM) by transient elastography (TE) has been repeatedly demonstrated as the reliable way to rule out the presence of high-risk esophageal varices (HRV). We aimed to evaluate and compare novel vs. standard TE-SSM module performance in diagnosing HRV in patients with compensated advanced chronic liver disease (cACLD). This retrospective study included patients with cACLD; blood data, upper digestive endoscopy performed within 3 months of TE, SSM@50Hz and SSM@100Hz were collected...
March 30, 2024: Diagnostics
https://read.qxmd.com/read/38611598/acoustic-radiation-forced-impulse-of-the-liver-and-the-spleen-combined-with-spleen-dimension-and-platelet-count-in-new-ratio-scores-identifies-high-risk-esophageal-varices-in-well-compensated-cirrhotic-patients
#5
JOURNAL ARTICLE
Antonio F M Vainieri, Elisa Brando, Antonio De Vincentis, Giulia Di Pasquale, Valentina Flagiello, Paolo Gallo, Francesca Barone, Teresa Massaro Cenere, Evelyn Di Matteo, Antonio Picardi, Giovanni Galati
Acoustic radiation forced impulse (ARFI) is an integrated ultrasound method, measuring stiffness by point shear wave elastography. To evaluate the diagnostic performance of the ARFI of the liver and the spleen, combined with spleen dimension and platelet count, in predicting high-risk esophageal varices (HRVs) in cirrhotic patients, a prospective and cross-sectional study was conducted between February 2017 and February 2021. The following ratio scores were calculated based on ARFI measurements: ALSDP (ARFI Liver-Spleen Diameter-to-Platelet Ratio Score), ASSDP (ARFI Spleen-Spleen Diameter-to-Platelet Ratio Score), ASSAP (ARFI Spleen-Spleen Area-to-Platelet Ratio Score), and ALSAP (ARFI Liver-Spleen Area-to-Platelet Ratio Score)...
March 25, 2024: Diagnostics
https://read.qxmd.com/read/38603605/isolated-gastric-varices-associated-with-antiphospholipid-syndrome-and-protein-s-deficiency-a-case-report-and-review-of-the-literature
#6
JOURNAL ARTICLE
Xueyan Li, Jiandi Wu, Feifei Fang, Ying Liu, Wewei Jiang, Gangping Li, Jun Song
The mortality rate of gastric varices bleeding can reach 20% within 6 weeks. Isolated gastric varices (IGVs) refer to gastric varices without esophageal varices and typically arise as a common complication of left portal hypertension. Although IGVs commonly form in the setting of splenic vein occlusion, the combination of antiphospholipid syndrome and protein S deficiency leading to splenic vein occlusion is rare. We herein present a case of a 28-year-old woman with intermittent epigastric pain and melena. She was diagnosed with antiphospholipid syndrome based on the triad of pregnancy morbidity, unexplained venous occlusion, and positive lupus anticoagulant...
April 2024: Journal of International Medical Research
https://read.qxmd.com/read/38592545/a-retrospective-multicentre-clinical-study-on-management-of-isolated-splenic-vein-thrombosis-risks-and-benefits-of-anticoagulation
#7
MULTICENTER STUDY
A M Eltweri, M Basamh, Y Y Ting, M Harris, G Garcea, L L Kuan
INTRODUCTION: Isolated splenic vein thrombosis (iSVT) is a common complication of pancreatic disease. Whilst patients remain asymptomatic, there is a risk of sinistral portal hypertension and subsequent bleeding from gastric varices if recanalisation does not occur. There is wide variation of iSVT treatment, even within single centres. We report outcomes of iSVT from tertiary referral hepatobiliary and pancreatic (HPB) units including the impact of anticoagulation on recanalisation rates and subsequent variceal bleeding risk...
April 9, 2024: Langenbeck's Archives of Surgery
https://read.qxmd.com/read/38592411/portal-vein-thrombosis-state-of-the-art-review
#8
REVIEW
Andrea Boccatonda, Simone Gentilini, Elisa Zanata, Chiara Simion, Carla Serra, Paolo Simioni, Fabio Piscaglia, Elena Campello, Walter Ageno
Background: Portal vein thrombosis (PVT) is a rare disease with an estimated incidence of 2 to 4 cases per 100,000 inhabitants. The most common predisposing conditions for PVT are chronic liver diseases (cirrhosis), primary or secondary hepatobiliary malignancy, major infectious or inflammatory abdominal disease, or myeloproliferative disorders. Methods: PVT can be classified on the basis of the anatomical site, the degree of venous occlusion, and the timing and type of presentation. The main differential diagnosis of PVT, both acute and chronic, is malignant portal vein invasion, most frequently by hepatocarcinoma, or constriction (typically by pancreatic cancer or cholangiocarcinoma)...
March 6, 2024: Journal of Clinical Medicine
https://read.qxmd.com/read/38590588/characteristics-and-related-factors-of-bacterial-infection-among-patients-with-cirrhosis
#9
JOURNAL ARTICLE
Nguyen-Thi Ngoc Lan, Dau Quang Lieu, Tran Ngoc Anh, Le Hoai Thuong, Tran-Thi Khanh Tuong, Mai Hong Bang
BACKGROUND: Infection causes cirrhosis to decompensate, affecting liver function and resulting in several complications, including esophageal variceal hemorrhage, hepatic encephalopathy, and hepatorenal syndrome. Objective: This study aimed to identify the prevalence, essential features, and related factors of bacterial infection among patients with cirrhosis in Vietnam. METHODS: This retrospective study included 317 patients diagnosed with cirrhosis, who were divided into two groups: group 1 including 125 patients with bacterial infection and group 2 including 192 patients without bacterial infection...
2024: Materia Socio-medica
https://read.qxmd.com/read/38586705/the-prediction-and-treatment-of-bleeding-esophageal-varices-in-the-artificial-intelligence-era-a-review
#10
REVIEW
María Isabel Murillo Pineda, Tania Siu Xiao, Edgar J Sanabria Herrera, Alberto Ayala Aguilar, David Arriaga Escamilla, Alejandra M Aleman Reyes, Andreina D Rojas Marron, Roberto R Fabila Lievano, Jessica J de Jesús Correa Gomez, Marily Martinez Ramirez
Esophageal varices (EVs), a significant complication of cirrhosis, present a considerable challenge in clinical practice due to their high risk of bleeding and associated morbidity and mortality. This manuscript explores the transformative role of artificial intelligence (AI) in the management of EV, particularly in enhancing diagnostic accuracy and predicting bleeding risks. It underscores the potential of AI in offering noninvasive, efficient alternatives to traditional diagnostic methods such as esophagogastroduodenoscopy (EGD)...
March 2024: Curēus
https://read.qxmd.com/read/38583800/endoscopic-submucosal-dissection-for-early-esophageal-squamous-cell-carcinoma-after-ligation-and-sclerotherapy-of-esophageal-and-gastric-varices
#11
JOURNAL ARTICLE
Sio-Hou Wong, Hoi-Ioi Ng, Yong Liu, Hon-Ho Yu, Gui-Qi Wang
Esophageal cancer ranked ten of the most common cancers in China. With the advancement of high-quality endoscopy and chromoendoscopic technique, early esophageal cancer can be diagnosed more easily, even combined with esophageal-gastric fundal varices. Endoscopic resection of early esophageal cancer is a minimally invasive treatment method for early esophageal cancer, and endoscopic submucosal dissection (ESD) is one of the standard treatments for early esophageal cancer in view of the risk of bleeding, the patient in this study successfully received ESD treatment after using endoscopic variceal ligation and endoscopic injection of tissue glue and sclerosing agent before ESD surgery...
April 5, 2024: Clinics and Research in Hepatology and Gastroenterology
https://read.qxmd.com/read/38583118/a-case-of-recurrent-follicular-cholangitis-leading-to-decompensated-cirrhosis-after-left-sided-hepatectomy
#12
JOURNAL ARTICLE
Hirotaka Oura, Takayoshi Nishino, Yasuki Hatayama, Harutoshi Sugiyama, Makoto Arai, Akihiro Cho, Satoshi Katagiri, Keita Yoshida, Takuya Nagasaka, Tadao Nakazawa
Follicular cholangitis (FC) is a rare non-neoplastic biliary tract disease first reported in 2003. A 74-year-old woman underwent extended left hepatectomy with a diagnosis of intrahepatic cholangiocarcinoma. Histopathological examination of the surgical specimen demonstrated no malignant findings, and lymphocytic infiltration with lymphoid follicles was observed within the bile duct wall. Along with immunohistochemical findings, the patient was diagnosed with FC. More than 3 years after surgery, the patient exhibited elevated hepatobiliary enzymes and total bilirubin...
April 7, 2024: Clinical Journal of Gastroenterology
https://read.qxmd.com/read/38583112/clinical-risk-factors-for-portal-hypertension-related-complications-in-systemic-therapy-for-hepatocellular-carcinoma
#13
JOURNAL ARTICLE
Kisako Fujiwara, Takayuki Kondo, Kentaro Fujimoto, Sae Yumita, Keita Ogawa, Takamasa Ishino, Miyuki Nakagawa, Terunao Iwanaga, Satoshi Tsuchiya, Keisuke Koroki, Hiroaki Kanzaki, Masanori Inoue, Kazufumi Kobayashi, Soichiro Kiyono, Masato Nakamura, Naoya Kanogawa, Sadahisa Ogasawara, Shingo Nakamoto, Tetsuhiro Chiba, Jun Koizumi, Jun Kato, Naoya Kato
BACKGROUND: During systemic therapy, the management of portal hypertension (PH)-related complications is vital. This study aimed to clarify factors associated with the incidence and exacerbation of PH-related complications, including the usefulness of contrast-enhanced computed tomography (CECT) in the management of PH-related complications during systemic therapy. METHODS: A total of 669 patients who received systemic therapy as first-line treatment (443 patients for sorafenib, 131 for lenvatinib, and 90 for atezolizumab/bevacizumab [ATZ/BEV]) were enrolled in this retrospective study...
April 7, 2024: Journal of Gastroenterology
https://read.qxmd.com/read/38582609/esophagogastroduodenoscopy-findings-that-do-no-not-explain-dysphagia-are-associated-with-underutilization-of-high-resolution-manometry
#14
JOURNAL ARTICLE
Sydney Pomenti, John Nathanson, Meaghan Phipps, Chino Aneke-Nash, David Katzka, Daniel Freedberg, Daniela Jodorkovsky
In patients with dysphagia that is not explained by upper endoscopy, high-resolution esophageal manometry (HRM) is the next logical step in diagnostic testing. This study investigated predictors of failure to refer for HRM after an upper endoscopy that was performed for but did not explain dysphagia. This was a retrospective cohort study of patients >18 years of age who underwent esophagogastroduodenoscopy (EGD) for dysphagia from 2015 to 2021. Patients with EGD findings that explained dysphagia (e.g. esophageal mass, eosinophilic esophagitis, Schatzki ring, etc...
April 6, 2024: Diseases of the Esophagus: Official Journal of the International Society for Diseases of the Esophagus
https://read.qxmd.com/read/38577650/future-directions-of-noninvasive-prediction-of-esophageal-variceal-bleeding-no-worry-about-the-present-computed-tomography-inefficiency
#15
EDITORIAL
Yu-Hang Zhang, Bing Hu
In this editorial, we comment on the minireview by Martino A, published in the recent issue of World Journal of Gastrointestinal Endoscopy 2023; 15 (12): 681-689. We focused mainly on the possibility of replacing the hepatic venous pressure gradient (HVPG) and endoscopy with noninvasive methods for predicting esophageal variceal bleeding. The risk factors for bleeding were the size of the varices, the red sign and the Child-Pugh score. The intrinsic core factor that drove these changes was the HVPG. Therefore, the present studies investigating noninvasive methods, including computed tomography, magnetic resonance imaging, elastography, and laboratory tests, are working on correlating imaging or serum marker data with intravenous pressure and clinical outcomes, such as bleeding...
March 16, 2024: World Journal of Gastrointestinal Endoscopy
https://read.qxmd.com/read/38577649/computed-tomography-for-prediction-of-esophageal-variceal-bleeding
#16
JOURNAL ARTICLE
Mohammed Elhendawy, Ferial Elkalla
This letter to the editor relates to the study entitled "The role of computed tomography for the prediction of esophageal variceal bleeding: Current status and future perspectives". Esophageal variceal bleeding (EVB) is one of the most common and severe complications related to portal hypertension (PH). Despite marked advances in its management during the last three decades, EVB is still associated with significant morbidity and mortality. The risk of first EVB is related to the severity of both PH and liver disease, and to the size and endoscopic appearance of esophageal varices...
March 16, 2024: World Journal of Gastrointestinal Endoscopy
https://read.qxmd.com/read/38577645/computed-tomography-for-the-prediction-of-oesophageal-variceal-bleeding-a-surrogate-or-complementary-to-the-gold-standard
#17
EDITORIAL
Yasser Fouad, Mohamed Alboraie
In this editorial we comment on the in-press article in the World Journal of Gastrointestinal endoscopy about the role of computed tomography (CT) for the prediction of esophageal variceal bleeding. The mortality and morbidity are much increased in patients with chronic liver diseases when complicated with variceal bleeding. Predicting the patient at a risk of bleeding is extremely important and receives a great deal of attention, paving the way for primary prophylaxis either using medical treatment including carvedilol or propranolol, or endoscopic band ligation...
March 16, 2024: World Journal of Gastrointestinal Endoscopy
https://read.qxmd.com/read/38565487/progression-of-portal-hypertension-after-atezolizumab-plus-bevacizumab-for-hepatocellular-carcinoma-report-a-case-and-literature-review
#18
Tung-Yen Lin, Tung-Hung Su
BACKGROUND: Atezolizumab/bevacizumab combination therapy became the first-line therapy for advanced hepatocellular carcinoma (HCC). Gastroesophageal varices should be monitored and managed before treatment. The progression of portal hypertension during bevacizumab-containing therapy is unclear. METHOD: A case of new development of esophageal varices, ascites, and hepatic hydrothorax during atezolizumab/bevacizumab therapy at National Taiwan University Hospital was reported, and relevant literature was reviewed...
April 2, 2024: Journal of the Formosan Medical Association
https://read.qxmd.com/read/38562337/a-rare-case-of-portal-hypertension-and-ascites-following-intrauterine-fetal-death-a-case-report
#19
Aizaz A Shah, Vemparala Priyatha, Yamna Ali, Abdul Wahab, Mahejehan A Salarzai, Junaid Ahmad, Noman Salih
We present a rare case of a 25-year-old woman who developed idiopathic portal hypertension and ascites four days after delivering a stillborn child at term. She had no previous liver illness or risk factors for portal vein thrombosis. Investigations revealed a dilated portal vein, esophageal varices, and high serum-albumin gradient ascites, all of which point to a presinusoidal etiology of portal hypertension. There was no indication of cirrhosis, hepatic or portal vein thrombosis, metabolic or autoimmune liver diseases, or persistent infections...
March 2024: Curēus
https://read.qxmd.com/read/38549132/hcc-portal-hypertension-imaging-score-derived-from-ct-predicts-re-bleeding-and-mortality-after-acute-variceal-bleeding
#20
JOURNAL ARTICLE
Mingyuan Zhao, Binyue Zhang, Jianqiang Shi, Xiaoxian Tang, Hongxia Li, Shengwen Li, Yunfeng Yang, Yi Han, Rong Wang, Jian Xun, Kai Zhang, Xirun Wu, Jiang Zhao
BACKGROUND/PURPOSE: Risk factors for re-bleeding and death after acute variceal bleeding (AVB) in cirrhotic HCC patients are not fully understood.We aimed to (1) explore how the combination of high-risk esophageal varices, HCC status, and portal vein tumor thrombus (i.e., HCC Portal Hypertension Imaging Score [HCCPHTIS]) helps predict increased risk of variceal re-bleeding and mortality; (2) assess predictability and reproducibility of the identified variceal re-bleeding rules. METHODS: This prospective study included 195 HCC patients with first-time AVB and liver cirrhosis, and conducted multivariable Cox regression analysis and Kaplan-Meier analysis...
March 28, 2024: Cancer Imaging: the Official Publication of the International Cancer Imaging Society
keyword
keyword
22814
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.